Donald Ashley

Donald Ashley possesses extensive experience in regulatory compliance within the life sciences sector. As Principal at ELIQUENT Life Sciences, Donald Ashley has demonstrated expertise in navigating complex regulatory environments. Previously, Donald Ashley served as the Director of the Office of Compliance at the FDA's Center for Drug Evaluation and Research (CDER), overseeing critical compliance strategies and policies.